insights_auto
Why is MMQ0 up 2.45%?
Dive Deeperchevron_right
MMQ0:FRA
Definium Therapeutics Inc
€29.30
arrow_upward
+2.45%(+0.70) 1D
Oct 19, 10:00:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MMQ0...
Open
€27.30
High
€29.40
Low
€27.30
Mkt. cap
4.43B
Avg. vol.
33.00
Volume
140.00
52-wk high
€42.70
52-wk low
€12.81
No. of employees
106
Open
€27.30
High
€29.40
Low
€27.30
Mkt. cap
4.43B
Avg. vol.
33.00
Volume
140.00
52-wk high
€42.70
52-wk low
€12.81
No. of employees
106
News stories
From web sources and news partners
Investing.com
·
11 hours ago
RBC Capital reiterates Definium Therapeutics stock rating on strong trial data
Profile
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs. Wikipedia
About Definium Therapeutics Inc
CEORobert Barrow
Employees106
Founded2010
Headquarters-
SectorPharmaceutical industry
Websitedefiniumtx.com